Established in 2010 by inventor Avraham Shekalim, LioMed is dedicated to creating groundbreaking medical devices and launching new companies.
The company oversees R&D processes, feasibility evaluations, prototyping, intellectual property safeguarding, and early-stage funding—providing all the essentials to help medical device start-ups become independent.
Each spin-off is equipped with prototypes and patent applications to facilitate their initial growth.
Our Achievements and Services
LioMed has successfully initiated several start-ups, each introducing innovative medical technologies and attracting notable investment. In addition, the company offers comprehensive engineering, development, and consulting services.
Highlighted Spin-Offs:
- CardioSert Ltd.: Specializes in devices for opening CTO coronary arteries and measuring fractional flow reserve (FFR).
- MicroSert Ltd.: Develops miniature intraocular implants designed for long-term drug delivery in chronic eye conditions.
- NovoSert Ltd.: Produces angioplasty balloon catheters for treating calcified coronary lesions.
- BioSert Ltd.: Focuses on bioabsorbable stents aimed at reducing restenosis within stents.
Founder & CEO: Avraham Shekalim
Avraham Shekalim brings over four decades of entrepreneurial expertise to LioMed, holding more than 70 international patents. He has led numerous pioneering medical device firms and research teams throughout his distinguished career.
